Plasma cell densities and glomerular filtration rates predict renal allograft outcomes following acute rejection

Transplant International

Volumn 25, Issue 10, 2012, Pages 1050-1058

  Chang, Anthony ^a   Moore, Jocelyn M ^a   Cowan, Michelle L ^a   Josephson, Michelle A ^a   Chon, W James ^a   Sciammas, Roger ^a   Du, Zeying ^a   Marino, Susana R ^a   Meehan, Shane M ^a   Millis, Michael ^a   David, Michael Z ^a   Williams, James W ^a   Chong, Anita S ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

allograft rejection; B cells; immunohistochemistry; plasma cells

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD45 ANTIGEN; CORTICOSTEROID; IMMUNOGLOBULIN G; RITUXIMAB; SYNDECAN 1; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; B LYMPHOCYTE; CELL DENSITY; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FIBROSIS; MAJOR CLINICAL STUDY; MALE; PLASMA CELL; PLASMAPHERESIS; PREDICTIVE VALUE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; ANTIGENS, CD20; ANTIGENS, CD3; B-LYMPHOCYTES; BIOPSY; COMPLEMENT C4B; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PLASMA CELLS; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY; SYNDECAN-1; TRANSPLANTATION, HOMOLOGOUS;

EID: 84866269293     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2012.01531.x     Document Type: Article

References (40)

1. Lakkis FG, Arakelov A, Konieczny BT, Inoue Y,. Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med 2000; 6: 686.
2. Arakelov A, Lakkis FG,. The alloimmune response and effector mechanisms of allograft rejection. Semin Nephrol 2000; 20: 95.
3. Game DS, Warrens AN, Lechler RI,. Rejection mechanisms in transplantation. Wien Klin Wochenschr 2001; 113: 832.
4. Taylor AL, Watson CJ, Bradley JA,. Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy. Crit Rev Oncol Hematol 2005; 56: 23.
5. Tonshoff B, Hocker B,. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity. Pediatr Transplant 2006; 10: 721.
6. Lamb KE, Lodhi S, Meier-Kriesche HU,. Long-term renal allograft survival in the United States: a critical reappraisal. Am J Transplant 2005; 11: 450.
7. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B,. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378.
8. Feucht HE, Schneeberger H, Hillebrand G, et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993; 43: 1333.
9. Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria-an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708.
10. Haas M,. The significance of C4d staining with minimal histologic abnormalities. Curr Opin Organ Transplant 2006; 15: 21.
11. Regele H, Exner M, Watschinger B, et al. Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection. Nephrol Dial Transplant 2001; 16: 2058.
12. Nickeleit V, Zeiler M, Gudat F, Thiel G, Mihatsch MJ,. Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. J Am Soc Nephrol 2002; 13: 242.
13. Bohmig GA, Exner M, Watschinger B, et al. C4d deposits in renal allografts are associated with inferior graft outcome. Transplant Proc 2001; 33: 1151.
14. Sureshkumar KK, Hussain SM, Carpenter BJ, Sandroni SE, Marcus RJ,. Antibody-mediated rejection following renal transplantation. Expert Opin Pharmacother 2007; 8: 913.
15. Venetz JP, Pascual M,. New treatments for acute humoral rejection of kidney allografts. Expert Opin Investig Drugs 2007; 16: 625.
16. Becker YT, Samaniego-Picota M, Sollinger HW,. The emerging role of rituximab in organ transplantation. Transpl Int 2006; 19: 621.
17. Singh N, Pirsch J, Samaniego M,. Antibody-mediated rejection: treatment alternatives and outcomes. Transplant Rev (Orlando) 2009; 23: 34.
18. Jordan SC, Peng A, Vo AA,. Therapeutic strategies in management of the highly HLA-sensitized and ABO-incompatible transplant recipients. Contrib Nephrol 2009; 162: 13.
19. Loupy A, Hill GS, Suberbielle C, et al. Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). Am J Transplant 2005; 11: 56.
20. El Karoui K, Hill GS, Karras A, et al. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies. Kidney Int 2007; 79: 643.
21. Haririan A, Kiangkitiwan B, Kukuruga D, et al. The impact of c4d pattern and donor-specific antibody on graft survival in recipients requiring indication renal allograft biopsy. Am J Transplant 2009; 9: 2758.
22. Mannon RB, Matas AJ, Grande J, et al. Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant 2005; 10: 2066.
23. Sis B, Jhangri GS, Bunnag S, Allanach K, Kaplan B, Halloran PF,. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009; 9: 2312.
24. Sarwal M, Chua MS, Kambham N, et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 2003; 349: 125.
25. Hippen BE, DeMattos A, Cook WJ, Kew CE 2nd, Gaston RS,. Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts. Am J Transplant 2005; 5: 2248.
26. Kayler LK, Lakkis FG, Morgan C, et al. Acute cellular rejection with CD20-positive lymphoid clusters in kidney transplant patients following lymphocyte depletion. Am J Transplant 2007; 7: 949.
27. Muorah MR, Brogan PA, Sebire NJ, Trompeter RS, Marks SD,. Dense B cell infiltrates in paediatric renal transplant biopsies are predictive of allograft loss. Pediatr Transplant 2009; 13: 217.
28. Scheepstra C, Bemelman FJ, van der Loos C, et al. B cells in cluster or in a scattered pattern do not correlate with clinical outcome of renal allograft rejection. Transplantation 2008; 86: 772.
29. Tsai EW, Rianthavorn P, Gjertson DW, Wallace WD, Reed EF, Ettenger RB,. CD20+ lymphocytes in renal allografts are associated with poor graft survival in pediatric patients. Transplantation 2006; 82: 1769.
30. Bagnasco SM, Tsai W, Rahman MH, et al. CD20-positive infiltrates in renal allograft biopsies with acute cellular rejection are not associated with worse graft survival. Am J Transplant 2007; 7: 1968.
31. Zarkhin V, Li L, Sarwal M,. "To B or not to B?" B-cells and graft rejection. Transplantation 2008; 85: 1705.
32. Sis B, Mengel M, Haas M, et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464.
33. Myers GL, Miller WG, Coresh J, et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 2006; 52: 5.
34. Stevens LA, Coresh J, Greene T, Levey AS,. Assessing kidney function - measured and estimated glomerular filtration rate. N Engl J Med 2006; 354: 2473.
35. Einecke G, Sis B, Reeve J, et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9: 2520.
36. Charney DA, Nadasdy T, Lo AW, Racusen LC,. Plasma cell-rich acute renal allograft rejection. Transplantation 1999; 68: 791.
37. Gartner V, Eigentler TK, Viebahn R,. Plasma cell-rich rejection processes in renal transplantation: morphology and prognostic relevance. Transplantation 2006; 81: 986.
38. Meehan SM, Domer P, Josephson M, et al. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. Hum Pathol 2001; 32: 205.
39. Burns AM, Chong AS,. Alloantibodies prevent the induction of transplantation tolerance by enhancing alloreactive T cell priming. J Immunol 2011; 186: 214.
40. Burns AM, Ma L, Li Y, et al. Memory alloreactive B cells and alloantibodies prevent anti-CD154-mediated allograft acceptance. J Immunol 2009; 182: 1314.